Angene Chemical
Draw
|
Currency :
Home Products

AG00E9EW

635702-64-6 | 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride

Chemical structure of 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride, CAS 635702-64-6
AG00E9EW
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 635702-64-6
Catalog Number AG00E9EW(AGN-PC-00AVYH)
Chemical Name 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride
IUPAC Name 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
InChI InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H
InChI Key MQHIQUBXFFAOMK-UHFFFAOYSA-N
MDL Number MFCD12546138
Molecular Formula C21H24ClN7O2S
Molecular Weight 473.9790
NSC Number 737754
SMILES O=S(C1=CC(NC2=NC=CC(N(C3=CC4=NN(C)C(C)=C4C=C3)C)=N2)=CC=C1C)(N)=O.[H]Cl
UNII 33Y9ANM545
Synonyms
GW 780604, GW 786034B, GW-780604, GW-786034B, GW780604, GW786034B, pazopanib, Votrient, Pazopanib hydrochloride, 635702-64-6, pazopanib HCl, Votrient, Pazopanib (Hydrochloride), Armala, UNII-33Y9ANM545, Pazopanib HCl (GW786034 HCl), GW786034B, pazopanib monohydrochloride, GW 786034, GW786034 HCl, CHEBI:71217, 33Y9ANM545, AK163181, S1035, C21H23N7O2S.HCl, 5-((4-((2,3-DIMETHYL-2H-INDAZOL-6-YL)(METHYL)AMINO)PYRIMIDIN-2-YL)AMINO)-2-METHYLBENZENESULFONAMIDE HYDROCHLORIDE, 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride, 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide hydrochloride, Patorma, Votrient (TN), 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride, 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide hydrochloride, Pazopanib hydrochloride [USAN:JAN], GW-786034B, Pazopanib-Hydrochloride, MLS004774147, SCHEMBL159487, SYN1058A, CHEMBL1201733, DTXSID70212956, EX-A956, MQHIQUBXFFAOMK-UHFFFAOYSA-N, Pazopanib HCl (GW786034 ), BCP02203, Pazopanib hydrochloride (JAN/USAN), MFCD12546138, NSC737754, AKOS015958593, BCP9001052, CS-0126, GSK-786034, KS-1458, NSC-737754, PB31655, SB10367, KS-000003E0, AC-24726, AK-77387, AN-16933, HY-12009, SC-90768, SMR003500790, GW786034GW786034, AX8294838, AM20090655, FT-0687642, ST24048877, SW218082-2, X3177, EC-000.2347, D05380, W-5532, A834417, 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide Hydrochloride, 5-({4-[(2,3-dimethylindazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride, 5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide hydrochloride, 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride, 5-{4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide hydrochloride, Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, monohydrochloride, Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1), Pazopanib, cc-527, Pazopanib Hydrochloride [USAN], GW786034, CS-CW-00177, Pazopanib Hydrochloride (GW786034), ACN-041320, GW 786034B, CID11525740, GW780604, GW 780604, GW-780604, GW-786034, 2631S, A8347, A10699, C516667, 444731-52-6,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited